This variant has been found to decrease CASP8 activity and apoptotic reactivity of T lymphocytes through the cancer cell ex vivo model [8], and the decreased CASP8 activity may lead to an alteration of normal programmed cell death and result in tumor susceptibility. This evidence concerns the gene CASP8 and neoplasm.